GenomeNext
Company

Last deal

$1.2M

Amount

Seed

Stage

24.02.2016

Date

1

all rounds

$1.2M

Total amount

date founded

Financing round

General

About Company
GenomeNext offers an automated genomic analysis solution for researchers and clinicians.

Industry

Sector :

Subsector :

Keywords :

founded date

15.03.2014

Number of employees

Company Type

For Profit

Last funding type

Seed

IPO status

Private

Description

The GenomeNext analysis pipeline can deliver accurate and reproducible genomic analysis results from FASTQ to VCF to annotation in under 2 hours for whole genomes, under 1 hour per exome, and 30 minutes per panel. The analysis pipeline follows best practices for both single sample and multisample variant discovery, and each step has been carefully designed to align raw sequence reads, refine alignment, clean up artifacts, and perform variant and genotype discovery with a high degree of confidence. The automated analysis platform features cost-effective solutions for clinical and research needs, regulatory compliance, secure storage, and collaboration for teams with unlimited user accounts.
Contacts

Contact Email

Social url

Similar Companies
1000
iBinom

iBinom

iBinom is a SaaS-based platform that offers fast and affordable human genome interpretation services.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Moscow, Russia

total rounds

2

total raised

$400K
GPAS

GPAS

GPAS provides rapid, standardized genomic analysis for global health improvement.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

London, UK
Bluebee

Bluebee

Bluebee is a bio-informatics platform that processes, analyzes, shares and stores genomics data.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Analytics, Health Care

Location

Rijswijk, Netherlands

total rounds

2

total raised

$13.32M
Cypher Genomics

Cypher Genomics

Cypher Genomics provides automated genome interpretation for diagnostics development and biomarkers.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

San Diego, CA, USA

total rounds

2

Financials

Funding Rounds
1
1

Number of Funding Rounds

$1.2M

Money Raised

Their latest funding was raised on 24.02.2016. Their latest investor Hydra Capital. Their latest round Seed

Date 
Funding Round 
Investors 
Money Raised 
Lead 
24.02.2016
1
$1.2M

Hydra Capital

Hydra Capital is an investment firm with a diverse portfolio.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Washington Cir NW, Washington, DC, USA

count Of Investments

1
Co-Investors
Investors
1
1

Number of lead investors

1

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Seed

Hydra Capital

Hydra Capital is an investment firm with a diverse portfolio.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Washington Cir NW, Washington, DC, USA

count Of Investments

1

People

Founders
2

Christopher S. Drescher

Chris Drescher is a Co-Founder & President at GenomeNext.

current job

LabCorp
LabCorp

organization founded

1

Christopher S. Drescher

James Hirmas
James Hirmas

James Hirmas

James Hirmas is the VP of Research and Development at BeerBoard.

current job

BeerBoard
BeerBoard

organization founded

2

James Hirmas

Employee Profiles
5

Hemant Datta

Board member

Peter White

Peter White

Co-Founder and Chief Scientific Advisor

Activity

Recent News
0